Copyright
©The Author(s) 2024.
World J Crit Care Med. Jun 9, 2024; 13(2): 91225
Published online Jun 9, 2024. doi: 10.5492/wjccm.v13.i2.91225
Published online Jun 9, 2024. doi: 10.5492/wjccm.v13.i2.91225
Ref. | Acronym/Abbreviation | Country, number of participating sites | Number of patients | Type of patient population | Severity of ARDS | Intervention group | Control group | Primary outcome | Remarks |
Tomazini et al[15], 2020 | CoDEX | Brazil, 41 | 299 | Adults with COVID-19 ARDS on mechanical ventilation | Moderate-to- severe | Standard care plus IV Dexamethasone 20 mg once daily for 5 d followed by 10 mg once daily for 5 d or until ICU discharge, whichever occurred first | Standard care | VFD at 28 d | Open-label trial with no blinding leading to high number of patients in control group receiving corticosteroids |
- Citation: Sinha S, Patnaik R, Behera S. Steroids in acute respiratory distress syndrome: A panacea or still a puzzle? World J Crit Care Med 2024; 13(2): 91225
- URL: https://www.wjgnet.com/2220-3141/full/v13/i2/91225.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v13.i2.91225